Philip C. Schouten

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 854 citations

Tumor Immunology, Breast Oncology, Cancer Immunosurveillance +10

REV7 counteracts DNA double-strand break resection and affects PARP inhibition

Guotai Xu, J. Ross Chapman, Inger Brandsma et al. · Nature · 2015 · 583 citations · Full text

Chromatin, Genome Instability, Parp Inhibition +6

Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas

Marthe M. de Jonge, Aurélie Auguste, Lise M. van Wijk et al. · Clinical Cancer Research · 2018 · 207 citations · Full text

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

Magali Michaut, Suet‐Feung Chin, Ian J. Majewski et al. · Scientific Reports · 2016 · 173 citations · Full text

BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential

Tesa Severson, Justine Peeters, Ian J. Majewski et al. · Molecular Oncology · 2015 · 72 citations · Full text